CG Oncology CGON
NASDAQ CGON
$74.42 +0.08 (+0.11%)
As of: Sep 4, 2026 · 2:27 PM EDT

CG Oncology (CGON) Treasury Shares (2023)

CG Oncology's (CGON) quarterly Treasury Shares came in at $165373.0 in Q1 2026, down 0.58% on a QoQ basis from $166342.0 in Q4 2025.

Analysis

CG Oncology (CGON) Treasury Shares (2023) Analysis & Trends

CG Oncology (CGON) has 3 years of Treasury Shares data on file, last reported at $165373.0 in Q1 2026.

  • Quarterly Treasury Shares changed N/A year-over-year to $165373.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $165373.0 (changed N/A YoY) and the FY2025 annual result came in at $166342.0, changed N/A from the prior year.
  • Treasury Shares slipped to $165373.0 in Q1 2026, from $166342.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $81.6 million in Q4 2023 to a low of $94624.0 in Q3 2025.
  • A 3-year average of $33.3 million and a median of $23.9 million in 2023 frame the typical range for Treasury Shares.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn 36.40 Mn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn -
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn -
5 Revolution Medicines 44.04 Bn 44.04 Bn - -
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn -
8 Royalty Pharma 28.41 Bn 27.57 Bn - 2.72 Mn
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn -
10 CG Oncology 6.56 Bn 6.56 Bn -2.77 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 112.42 Mn
Dec 31, 2023 112.42 Mn
Sep 30, 2023 112.42 Mn
Sep 30, 2023 112.42 Mn
Jun 30, 2023 112.42 Mn
Jun 30, 2023 112.42 Mn
Mar 31, 2023 112.42 Mn
Mar 31, 2023 112.42 Mn